- Home
- ALAR vs COYA Comparison
ALAR vs COYA Comparison
Compare ALAR & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- COYA
- Stock Information
- Founded
- ALAR 2013
- COYA 2020
- Country
- ALAR Israel
- COYA United States
- Employees
- ALAR N/A
- COYA N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- COYA Health Care
- Exchange
- ALAR Nasdaq
- COYA Nasdaq
- Market Cap
- ALAR 105.3M
- COYA 107.0M
- IPO Year
- ALAR 2018
- COYA 2022
- Fundamental
- Price
- ALAR $14.58
- COYA $6.21
- Analyst Decision
- ALAR Strong Buy
- COYA Strong Buy
- Analyst Count
- ALAR 1
- COYA 5
- Target Price
- ALAR $27.00
- COYA $16.20
- AVG Volume (30 Days)
- ALAR 61.0K
- COYA 74.6K
- Earning Date
- ALAR 11-24-2025
- COYA 11-05-2025
- Dividend Yield
- ALAR N/A
- COYA N/A
- EPS Growth
- ALAR N/A
- COYA N/A
- EPS
- ALAR 0.07
- COYA N/A
- Revenue
- ALAR $30,488,000.00
- COYA $423,452.00
- Revenue This Year
- ALAR $28.77
- COYA $40.80
- Revenue Next Year
- ALAR $31.83
- COYA N/A
- P/E Ratio
- ALAR $19.25
- COYA N/A
- Revenue Growth
- ALAR N/A
- COYA N/A
- 52 Week Low
- ALAR $5.45
- COYA $4.65
- 52 Week High
- ALAR $21.50
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- ALAR 43.83
- COYA 55.05
- Support Level
- ALAR $14.23
- COYA $5.10
- Resistance Level
- ALAR $15.74
- COYA $6.70
- Average True Range (ATR)
- ALAR 0.64
- COYA 0.30
- MACD
- ALAR -0.14
- COYA 0.10
- Stochastic Oscillator
- ALAR 12.35
- COYA 71.84
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.